CIK 0001347178
- Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 030491827
- Phone
- +1 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- Open-market buys, last 90 days
- $38,094
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-03-10 | Kelly James Patrick SVP, CFO, Sec & Treasurer | Exercise or conversion · Restricted Stock Unit | −4,687 | 4,688 | ||
| 2015-03-10 | Kelly James Patrick SVP, CFO, Sec & Treasurer | Exercise or conversion · Restricted Stock Unit | −2,344 | 4,688 | ||
| 2015-03-10 | Kelly James Patrick SVP, CFO, Sec & Treasurer | Exercise or conversion · Restricted Stock Unit | −5,000 | 15,000 | ||
| 2015-03-10 | Baroldi Paolo SVP & Chief Medical Officer | Exercise or conversion | +12,500 | 34,485 | ||
| 2015-03-10 | Baroldi Paolo SVP & Chief Medical Officer | Exercise or conversion | +5,000 | 39,485 | ||
| 2015-03-10 | Baroldi Paolo SVP & Chief Medical Officer | Sale | −8,940 | $10.54 | $94K | 30,545 |
| 2015-03-10 | Baroldi Paolo SVP & Chief Medical Officer | Exercise or conversion · Restricted Stock Unit | −12,500 | 25,000 | ||
| 2015-03-10 | Baroldi Paolo SVP & Chief Medical Officer | Exercise or conversion · Restricted Stock Unit | −5,000 | 15,000 | ||
| 2015-03-09 | DUGAN RICHARD W Director | Exercise or conversion | +10,574 | $4.73 | $50K | 10,574 |
| 2015-03-09 | DUGAN RICHARD W Director | Sale | −4,804 | $10.69 | $51K | 5,770 |
| 2015-03-09 | DUGAN RICHARD W Director | Exercise or conversion · Nonqualified Stock Option (Right to Buy) | −10,574 | 0 | ||
| 2015-02-05 | Polymeropoulos Mihael Hristos President and CEO | Exercise or conversion | +48,154 | $0.03 | $2K | 552,018 |
| 2015-02-05 | Polymeropoulos Mihael Hristos President and CEO | Shares withheld for taxes | −24,947 | $11.28 | $281K | 527,071 |
| 2015-02-05 | Polymeropoulos Mihael Hristos President and CEO | Exercise or conversion · Employee Stock Option (Right to Buy) | −48,154 | 0 | ||
| 2014-12-23 | Flynn James E 10% owner | Purchase | +11,100 | $14.23 | $158K | 1,285,881 |
| 2014-12-23 | Flynn James E 10% owner | Purchase | +13,900 | $14.23 | $198K | 1,598,601 |
| 2014-12-23 | Flynn James E 10% owner | Purchase | +13,320 | $14.48 | $193K | 1,299,201 |
| 2014-12-23 | Flynn James E 10% owner | Purchase | +16,680 | $14.48 | $242K | 1,615,281 |
| 2014-12-23 | Flynn James E 10% owner | Purchase | +11,100 | $14.50 | $161K | 1,310,301 |
| 2014-12-23 | Flynn James E 10% owner | Purchase | +13,900 | $14.50 | $202K | 1,629,181 |
Page 30 of 36 · 717 trades